CLINICAL ROLE -
Multiple Sclerosis Palliative Care Spikes in United States
The rate of palliative care in patients with multiple sclerosis to have died in US hospitals increased from 7.7% to 58.8% over 10 years
Flu Vaccination Reminders Prove Effective for Patients With Diabetes
Influenza vaccinations among patients with diabetes rose by 20% when they were notified about scheduling their flu shot, according to a new study.
Lifestyle Choices May Drive Depression Associated with Multiple Sclerosis
Health care providers managing patients with MS should remain cognizant of the link between unhealthy lifestyle behaviors and depression risks.
Hispanics with HIV at Greater Risk of HPV-Related Cancers
Hispanic adults in the US who are infected with human immunodeficiency virus face a greater risk of cancers caused by human papillomavirus (HPV) than Hispanics in the general public.
Persistent Stigma Among Providers Inhibits HIV Prevention Goals
Stigma may cause undiagnosed individuals with HIV to go unidentified and fail to get quality care and treatment.
Growing Evidence Shows Hepatitis C Intersects With Other Diseases
A majority of patients with hepatitis C experience disorders outside of the liver that are related to the virus.
Rise in Hepatitis C Mirrors Injection Opioid Use Increase
CDC notes link between jump in acute HCV cases and admissions to substance use disorder treatment facilities for opioid injections.
Strategies to Reduce In Utero Transmission of Hepatitis C Virus
Thus far there is no intervention that clearly reduces the risk of HCV infection from a mother to her child.
Doctors Without Borders Challenges Hepatitis C Drug Patent
Sofosbuvir/velpatasvir is the first direct acting antiviral therapy registered for use against all 6 genotypes of hepatitis C.
New CDC Guidelines Target Hepatitis B
Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.
Patients With HIV Have Elevated Risk of Kidney Disease, Heart Attacks
HIV-positive patients need to maintain healthy body weight, quit smoking, eat well, exercise regularly and treat hypertension, diabetes and dyslipidemia.
Antiviral Drugs Maintain Cure Rates Across HIV-Hepatitis C Coinfection
Direct-acting antivirals drugs show similar cure rates in co-infected patients as high as mono-infected patients.
United States Falling Behind Other Countries Eliminating Hepatitis C
Nine other countries are on track to eliminate the hepatitis C virus by 2030.
Antiviral Drugs Improve Long-Term Quality of Life in Hepatitis C
Patients with hepatitis C who achieved sustained virologic response with a direct-acting antiviral maintained health improvements that enhanced their long-term quality of life.
Aspirin May Influence Liver Cancer Development in Hepatitis B
An aspirin a day may reduce their risk of hepatocellular carcinoma in patients with hepatitis B virus.
Hepatitis C Antivirals Safe in Heart Transplant Patients
Heart transplant patients with hepatitis C often cannot not tolerate interferon-based regimens due to cardiac toxicity and other heart-related problems.
Improving Synergy Among HIV Drugs to Increase Efficacy
Researchers evaluate potential reasons why HIV some drug combinations are more effective in certain patients.
Hepatitis C Elevates Chance of Miscarriage, Adverse Events in Pregnancy
Women with the hepatitis C virus have fewer live births and face a higher risk of miscarriage, infertility, gestational diabetes and pre-eclampsia.
Cost of Hepatitis C Antivirals May Keep Patients Away
Limited proportion of patients with chronic hepatitis C virus received antiviral treatment before the widespread use of direct-acting antivirals.
Sovaldi Effective in Hepatitis C Patients With Chronic Kidney Disease
Sofosbuvir may help improve the kidney function of some patients with hepatitis C virus.
Type 1 Diabetes Raises the Risk of Atrial Fibrillation in Women
The risk of irregular and rapid heartbeat increased in type 1 diabetic patients who had renal complications and poor glycemic control.
Gender Influences Hepatitis C Progression
Determining how hepatitis C progresses is important when considering therapies and the associated costs for different patient groups.
Hepatitis C Antiviral Drugs May Not Improve Liver Cancer Risk
The risk of developing liver cancer is similar with direct-acting antiviral drugs or interferon therapy for hepatitis C virus.
Alerts Increase Hepatitis C Screening Among Baby Boomers
Baby boomer hepatitis C virus screening rates spiked when a prompt in their electronic health records reminded a primary care provider to recommend testing.
Risk of Gestational Diabetes Rises from Weight Gain Between Pregnancies
Gestational diabetes mellitus can cause complications for both mothers and their babies.
Antiviral Drugs Reduce Liver Cancer Risk in Patients With Hepatitis C
New generation of antiviral drugs cause significant reduction in the risk for the most common type of adult liver cancer in patients with HCV.
Hepatitis C Cure Improves Glycemic Control in Type 2 Diabetes
Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.
Opioid Substitution Therapy Reduces Hepatitis C Reinfection
Wider access to new direct-acting antivirals for people who inject drugs may help reduce HCV infections.
Hepatitis C Treatment Outcomes Influenced by Genetics
Patient genotypes of in both hepatitis C and advanced cirrhosis may help predict outcomes with direct-acting antiviral drugs.
Updated Hepatitis C Guidelines Seek to Accelerate Testing Rates
TheÂ Guide to Hepatitis C TestingÂ addresses widespread uncertainty regarding HCV treatment.
2 Clarke Drive Cranbury, NJ 08512